x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr. Chapa’s OBGYN Clinical Pearls

Dr. Chapa’s Clinical Pearls

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

science

All Episodes

00:16:51

IC/Painful Bladder Syndrome (Part2): Treatment options

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/15

Treatment strategies for IC should proceed using more conservative therapies first with less conservative therapies employed if symptom control is inadequate for acceptable quality of life. Multiple, concurrent treatments may be considered if it is in the best interests of the patient. In this session, we will review the AUA clinical guidelines regarding management of IC with a review of the 1st-line to 6th-line treatment recommendations.

en

00:16:56

IC/Painful Bladder Syndrome: New AUA Guidelines

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/14

The effects of IC/BPS on psychosocial functioning and QoL are pervasive, damaging work life, psychological well-being, personal relationships and general health. There’s been a lot of new data regarding this condition and some historic information has been deleted. For example, potassium installation into the bladder is no longer recommended. That diagnostic test, occasionally still found in some gynecological texts, can cause exquisite pain if the bladder is acutely inflamed. Therefore, this is no

en

00:13:27

Funisitis

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/12

In 2017, the ACOG defined 3 classes of intraamniotic infection. Although most research/data has been on inflammation/infection of the placenta/membranes itself (chorioamnionitis), only recently has data on inflammation of the umbilical cord (funisitis) been forthcoming. Is inflammation of the umbilical cord directly related to microbial invasion? Does this have any neonatal implications? In this podcast we will review the pathological basis and clinical implications of funisitis.

en

00:07:49

OB Forceps’ Strange History

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/11

Obstetrical forceps have a strange history: considered by historians to have been created by William Chamberlain, a French surgeon, the tool was kept a close family “secret” for well over a century! Eventually, the device and concept was sold by a destitute Chamberlain family member. William Smellie would then take this device to the masses. In this podcast, we provide a brief historical perspective on obstetrical forceps.

en

00:02:46

9.1.1.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/11

Never. Forget.

en

00:11:27

Female Athlete Triad

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/11

Exercise in the young female adolescent is wonderful! But like everything else, too much can be dangerous. The Female Athlete Triad is marked by: 1. low energy availability, 2. menstrual dysfunction, and 3. low bone density. However, all 3 do not have to be present for the issue to be a concern. This condition is a spectrum! In this session, we will review committee opinion 702 from the ACOG, and learn more about the Female Athlete Triad.

en

00:13:39

Beyond Gardnerella: BV Biofilm New Data.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/08

Garderella Vaginalis may not be the only pathogen causing BV like symptoms. New data has linked BV with a vaginal BIOFILM ecosystem. It also increases the possible acquisition of other STIs, including HIV. In this session, we will review the pathophysiology, clinical symptoms, diagnostic methods, and of course treatment options for this common- and significant- vaginal condition. The recently FDA approved medication, Secnidazole, will also be briefly discussed (see separate, previous podcast).

en

00:13:25

Desquamative Inflammatory Vaginitis: An Old/New...

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/07

The human vaginal ecosystem is highly dynamic. The vaginal microbiome can affect host physiology, and vice versa. In 1965, Desquamative Inflammatory Vaginitis was 1st described, but the condition fell out of the spotlight. Recently, new data has brought this condition back into the light. How is this diagnosis made? Is vaginal culture recommended? That answer may surprise you. In this episode, we will review the latest information on Desquamative Inflammatory Vaginitis: its presentation, diagnosis,

en

00:09:02

BARE DOWN There? New data on STIs and going bare.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/05

Pubic hair grooming is a highly prevalent practice with self-reported rates between 75 to 99% of women. Does this increase STI risk? In this podcast, we will review a recent September 2019 open access publication by Luster et al. There may be more to the story than what’s presented in that study. Let’s look at that...now.

en

00:10:52

Best Vaginal Prep PreCS? A new systematic review &...

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/05

Post CS endometritis is thought to be linked to ascending vaginal bacteria. In 2016, the CSOAP trial concluded that adding ZMAX to standard antibiotic prophylaxis before non-elective CS helps reduce infection. But what about vaginal prep? What’s the best solution and concentration? In this session, we will summarize a new systematic review/meta-analysis from September 2019 published in AJOG.

en

00:11:49

Mycoplasma genitalium: An Overlooked STI.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/03

Mycoplasma genitalium is a facultative anaerobic organism which has been associated with cervicitis, endometritis, PID, infertility, susceptibility to HIV, and adverse birth outcomes, indicating a consistent relationship with female genital tract pathology. In 2015, the CDC listed it as an important, yet overlooked, STI. Now, a recently FDA approved test for the bacterium has increased awareness on this sexually transmitted pathogen. In this episode, we will review the microbiology, presentation,

en

00:10:56

Adolescent BC leads to Depression? Let’s see.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/02

Previous evidence suggests that use of oral contraceptives, especially during adolescence, may increase women’s vulnerability to depression in the short term. On August 28, 2019, a new publication by Canadian researchers in the Journal of Child Psychology and Psychiatry restated this association. Does this prove causation? Is it time to stop prescribing birth control to adolescents? Let’s take a critical look at this new study, as well as a prior 2016 publication, plus a 2018 systematic review, and

en

00:13:49

⚠️ Labor 2nd Stage: Too Long?

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/09/01

In 2014, the ACOG released a consensus statement, “Safe Prevention of the Primary Cesarean”. This extended the 2nd stage of labor by 1 hour. Was this evidence-based? New data suggest it was not, and may be harmful. In 2016, Leveno et al (Parkland Hospital) issued the first clinical commentary as a rebuttal to these changes citing lack of evidence to support the prolongation. In this session, we will review the upcoming publication (ahead of print) from Nelson, McIntire, and Leveno (Parkland

en

00:16:55

Wound Healing Principles: A clinical review.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/31

Wound healing is a complex and dynamic process! In this episode, we will review the 4 stages of wound healing using the analogy of “the broken house”. We will also describe the CDC criteria for surgical site infection (SSI) and review the 4 WHO classifications of wounds.

en

00:08:07

The V is NOT a TRUMPET! Air embolism after...

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/29

Air embolism during pregnancy has been reported… usually linked to blowing air into the vagina during orogenital sex. In this session, we will review the literature, presentation, and management of this uncommon- yet potentially lethal- occurrence.😳😳😳🤔

en

00:10:03

Testosterone Use in Women: Wonder-Drug or Waste?

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/27

There is currently no FDA approved testosterone products for women. Internet sources, and some pharmacies, offer a variety of testosterone products for use by women. Is this evidence-based? In this session, we will review the summary statements from the US Endocrine Society and the British Menopause Society regarding testosterone supplementation in women. (US Endocrine Society Data and the British Menopause Society. Thank you, Lisa Felsman, for the podcast topic!)

en

00:05:37

Fertility Meds Cause Breast CA? Let’s look at the data.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/26

Many studies have evaluated the relationship between fertility drugs and breast cancer. Are you aware of what the data shows? How would you cancel your patients? In this episode we will review the ASRM data regarding fertility medication use and breast cancer risk.

en

00:09:33

Fertility Meds Cause Ovarian CA? Let’s look at the data.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/25

The use of fertility drugs that may cause alterations in endogenous hormones and multiple ovulations has raised concerns about the long-term safety of such medications. One concern is that are invasive ovarian cancer. Is this concern evidence-based? In this session, we will review the ASRM Practice Guideline on the subject (2016), as well as a more recent updated ASCO/ESHRE review from 2018.

en

00:16:27

Amniotic Fluid Embolus

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/24

Amniotic fluid embolism is a rare but potentially lethal condition. Because of the rarity of this condition, most physicians and institutions have limited experience with the management of amniotic fluid embolism. The typical presentation of AFE includes a triad: sudden hypoxia hypotension, and coagulopathy. In this podcast, we will cover the latest data from the SMFM, ACOG, and AHA on this terrifying condition.

en

00:07:47

Uric Acid for Preeclampsia Eval? No.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/08/23

Serum uric acid levels are often ordered for the evaluation of hypertensive disorders of pregnancy. But why is this done? Is this test able to guide clinical management? A staple of PIH evaluation in the 1970s and 1980s, uric acid levels are still around. In this session, we will review why uric acid determinations for hypertensive disorders of pregnancy is not clinically useful – in general. Reference: Sept 2019 ACOG publication, “Questioning Clinical Practice”; Obstet Gynecol.

en

1,104 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter